3 Big Potential Catalysts for Moderna in 2021

1 min read

2020 is now hindsight. And what a year it was for Moderna (NASDAQ: MRNA).

The biotech became a household name as it regularly reported encouraging news for its COVID-19 vaccine candidate mRNA-1273. Its share price skyrocketed 434% (and peaked even higher than that). In December, mRNA-1273 became the second COVID-19 vaccine to win U.S. emergency use authorization (EUA). 

You might think that the new year could be kind of dull compared to all of that excitement. That won’t necessarily be the case, though. Here are three big potential catalysts for Moderna in 2021.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

A Basic Checklist for Filing Your Taxes

Next Story

Where Will Chipotle Be in 1 Year?

Latest from Blog